EPCAM and malignant colon neoplasm: EpAb2-6, a new EpCAM neutralizing antibody, exhibited antitumor effects via inhibiting the nuclear translocation of EpICD/β-catenin complexes and inducing apoptosis in colon cancer cells [19].